Effectiveness and Implementation of a Digital Intervention for Pediatric Chronic Pain Co-designed With Patients

ConditionChronic Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorUniversity of Malaga

About this trial

Children and adolescents with chronic pain often lack a proper diagnosis and treatment. Research has shown that, if left untreated, it usually doesn't resolve and continues through adulthood.

The goal of this multi-phase study is to co-develop (with patients), test, and implement a smartphone app called "Digital Solution for Pain in Adolescents" (Digital SPA) which can provide pain management resources to children with chronic pain and their parents, preventing future disability.

Participants will: participate in individual and group interviews, respond to questionnaires online and try a smartphone app.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adolescents age 12-17 years

Has had non-oncologic chronic pain for at least 3 months (e.g., abdominal pain, headache or musculoskeletal pain)

Has Internet access

One parent is willing to participate (and both give consent for their child to participate)

Disqualifiers

Diagnosis of a comorbid serious health condition (e.g., cancer)

Parent or child does not speak or read Spanish

Active psychosis or suicidal ideation

Trial design

Design model

Sequential

Treatments tested in this trial

  • Digital SPA

    Behavioral

    A psychological digital intervention for chronic pain in adolescents, based on evidence-based Acceptance and Commitment Therapy techniques. The intervention will be co-created with patients in a previous phase of the study, so the exact number or format of sessions and content has not been determined yet.

Treatment groups

195 Participants
are divided into 2 treatment groups
Group A: Digital SPAExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in Pain Interference

Spanish version of the Brief Pain Inventory (BPI) short version. Pain intensity scale scores range from from 0 to 10 , with higher scores indicating greater interference. Interference scores range from 0 to 10, with higher scores indicating greater interference.

Time frame
Pre-treatment (T1), Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).
2

Global impression of change after treatment

11-point scale (0 to 10) with higher scores indicating greater impression of change.

Time frame
Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).
3

Change in the number of visits to the Emergency Room (ER) due to pain

The number of visits to the ER due to pain during the follow-up period (T3 to T4; 3 months) will be compared with the three months before starting treatment (T1).

Time frame
Pre-treatment (T1), Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).

Secondary outcomes

1

Change in pain readiness to change

Readiness to adopt a self-management approach to pain. The Spanish version of the Pain Stages of Change Questionnaire for Adolescents (PSoCQ-A). The Questionnaire has three scales: Pre-contemplation, Contemplation, and Action/Maintenance. Each scale is scored in a 1 to 5 Likert scale, with higher scores indicating a higher level of attitudes in that stage of change. The scale with the highest score indicates which stage the respondent is at.

Time frame
Pre-treatment (T1), Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).
2

Change in the dose of pain medication taken

The dose (eg. 25 mg per day) of pain medication taken will be recorded.

Time frame
Pre-treatment (T1), Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).
3

Change in the type of pain medication taken

The type (e.g. Non-steroid Anti-inflammatory Drugs, opioids) of pain medication taken will be recorded.

Time frame
Pre-treatment (T1), Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).
4

Change in Emotional Distress

The Spanish version of the Social Emotional Distress Scale-Secondary (SEDS-S) will be administered to assess general emotional distress (internalizing symptoms such as anxiety and depression) over the past month. The SEDS-S is a 10-item self-report questionnaire; items are rated from 1 ("Not at all true") to 4 ("Very true / Absolutely true"), with higher total scores indicating greater emotional distress.

Time frame
Pre-treatment (T1), Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).

Other outcomes

1

Adverse Events (side effects)

Adverse Events are not expected given the content of the treatment and its non-invasive nature, however, they will be assessed, recorded and controlled for in the analyses

Time frame
Mid-treatment (T2; 4 weeks after T1), Post-treatment (T3; 8 weeks after T1) and 3-months follow-up (T4; 3 months after T3).

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Malaga

Lead sponsor

Ministerio de Ciencia e Innovación, Spain

Collaborator